Shopping Cart 0
Cart Subtotal
USD 0

Medicines for Malaria Venture - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Medicines for Malaria Venture (MMV) is a drug developing company that discovers and delivers new, effective and affordable antimalarial drugs. The center provides products that offers efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, safety in small children, safety in pregnancy, efficacy against plasmodium vivax, efficacy against severe malaria and transmission-blocking treatment, among others. It provides medicines for treatment of malaria which include quinine, chloroquine, sulphadoxine and pyremethamine, artamesinin, and others. MMV provides injectable artesunate tool kit and seasonal malaria chemoprevention (SMC) tool kit. The center collaborates with NGOs and non profit organizations and clinical centers. MMV is headquartered in Geneva, Switzerland.

Medicines for Malaria Venture-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicines for Malaria Venture, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Sumitomo Dainippon Pharma Enters into Research Agreement with Medicines for Malaria Venture 10

Astellas Pharma Enters into Agreement with Medicines for Malaria Venture 11

Janssen Pharma Enters into Agreement with Medicines for Malaria Venture 12

Daiichi Sankyo Enters into Research Agreement with Medicines for Malaria Venture 13

Mitsubishi Tanabe Pharma Enters into Research Agreement with Medicine for Malaria Venture 14

Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture 15

Novartis Expands its Agreement with Medicines for Malaria Venture 16

Eisai Enters into Research Agreement with Medicines for Malaria Venture 17

Sanofi-Aventis Extends Agreement with Medicines For Malaria Venture 18

Merck Serono Enters into Co-Development Agreement with MMV 19

Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab 20

Eisai Enters into Research Agreement with St. Jude Children's Research Hospital and Medicines For Malaria Venture to Develop SJ733 21

Takeda Pharma Enters into Agreement with Medicines for Malaria Venture 22

Medicines for Malaria Venture-Key Competitors 23

Medicines for Malaria Venture-Key Employees 24

Medicines for Malaria Venture-Locations And Subsidiaries 25

Head Office 25

Recent Developments 26

Government and Public Interest 26

Sep 08, 2017: Malaria: Drug Candidate May Reduce Spread of the Parasite 26

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Key Facts 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicines for Malaria Venture, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicines for Malaria Venture, Deals By Therapy Area, 2012 to YTD 2018 8

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sumitomo Dainippon Pharma Enters into Research Agreement with Medicines for Malaria Venture 10

Astellas Pharma Enters into Agreement with Medicines for Malaria Venture 11

Janssen Pharma Enters into Agreement with Medicines for Malaria Venture 12

Daiichi Sankyo Enters into Research Agreement with Medicines for Malaria Venture 13

Mitsubishi Tanabe Pharma Enters into Research Agreement with Medicine for Malaria Venture 14

Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture 15

Novartis Expands its Agreement with Medicines for Malaria Venture 16

Eisai Enters into Research Agreement with Medicines for Malaria Venture 17

Sanofi-Aventis Extends Agreement with Medicines For Malaria Venture 18

Merck Serono Enters into Co-Development Agreement with MMV 19

Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab 20

Eisai Enters into Research Agreement with St. Jude Children's Research Hospital and Medicines For Malaria Venture to Develop SJ733 21

Takeda Pharma Enters into Agreement with Medicines for Malaria Venture 22

Medicines for Malaria Venture, Key Competitors 23

Medicines for Malaria Venture, Key Employees 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Medicines for Malaria Venture, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Medicines for Malaria Venture (MMV) is a drug developing company that discovers and delivers new, effective and affordable antimalarial drugs. The center provides products that offers efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, safety in small children, safety in pregnancy, efficacy against plasmodium vivax, efficacy against severe malaria and transmission-blocking treatment, among others. It provides medicines for treatment of malaria which include quinine, chloroquine, sulphadoxine and pyremethamine, artamesinin, and others. MMV provides injectable artesunate tool kit and seasonal malaria chemoprevention (SMC) tool kit. The center collaborates with NGOs and non profit organizations and clinical centers. MMV is headquartered in Geneva, Switzerland.

Medicines for Malaria Venture-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicines for Malaria Venture, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Sumitomo Dainippon Pharma Enters into Research Agreement with Medicines for Malaria Venture 10

Astellas Pharma Enters into Agreement with Medicines for Malaria Venture 11

Janssen Pharma Enters into Agreement with Medicines for Malaria Venture 12

Daiichi Sankyo Enters into Research Agreement with Medicines for Malaria Venture 13

Mitsubishi Tanabe Pharma Enters into Research Agreement with Medicine for Malaria Venture 14

Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture 15

Novartis Expands its Agreement with Medicines for Malaria Venture 16

Eisai Enters into Research Agreement with Medicines for Malaria Venture 17

Sanofi-Aventis Extends Agreement with Medicines For Malaria Venture 18

Merck Serono Enters into Co-Development Agreement with MMV 19

Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab 20

Eisai Enters into Research Agreement with St. Jude Children's Research Hospital and Medicines For Malaria Venture to Develop SJ733 21

Takeda Pharma Enters into Agreement with Medicines for Malaria Venture 22

Medicines for Malaria Venture-Key Competitors 23

Medicines for Malaria Venture-Key Employees 24

Medicines for Malaria Venture-Locations And Subsidiaries 25

Head Office 25

Recent Developments 26

Government and Public Interest 26

Sep 08, 2017: Malaria: Drug Candidate May Reduce Spread of the Parasite 26

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Key Facts 2

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medicines for Malaria Venture, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medicines for Malaria Venture, Deals By Therapy Area, 2012 to YTD 2018 8

Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sumitomo Dainippon Pharma Enters into Research Agreement with Medicines for Malaria Venture 10

Astellas Pharma Enters into Agreement with Medicines for Malaria Venture 11

Janssen Pharma Enters into Agreement with Medicines for Malaria Venture 12

Daiichi Sankyo Enters into Research Agreement with Medicines for Malaria Venture 13

Mitsubishi Tanabe Pharma Enters into Research Agreement with Medicine for Malaria Venture 14

Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture 15

Novartis Expands its Agreement with Medicines for Malaria Venture 16

Eisai Enters into Research Agreement with Medicines for Malaria Venture 17

Sanofi-Aventis Extends Agreement with Medicines For Malaria Venture 18

Merck Serono Enters into Co-Development Agreement with MMV 19

Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab 20

Eisai Enters into Research Agreement with St. Jude Children's Research Hospital and Medicines For Malaria Venture to Develop SJ733 21

Takeda Pharma Enters into Agreement with Medicines for Malaria Venture 22

Medicines for Malaria Venture, Key Competitors 23

Medicines for Malaria Venture, Key Employees 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Medicines for Malaria Venture, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.